OTC/SmallCap IRW

China Telecom Honored with Three Awards including "Platinum Award", "Best CEO" and "Best Investor Relations Team" by The Asset

HONG KONG, Feb. 22, 2021 /PRNewswire/ -- China Telecom Corporation Limited ("China Telecom" or "the Company"; HKEx: 00728; NYSE: CHA) is pleased to announce that the Company was accredited with "Platinum Award – Excellence in Environmental, Social and Governance" in the poll of "ESG Corporate Awa...

2021-02-22 16:30 6466

Sasol delivered a good set of results for the six months ended 31 December 2020

JOHANNESBURG, Feb. 22, 2021 /PRNewswire/ -- Sasol delivered a good set of results for the six months ended31 December 2020. Our earnings increased by more than 100% to R15,3 billion from R4,5 billion in the prior period. Despite a 23% decrease in the rand/barrel oil price, our adjusted EBITDA de...

2021-02-22 15:21 4650

Elekta establishes office in Egypt to meet growing need for precision radiation medicine

STOCKHOLM, Feb. 22, 2021 /PRNewswire/ -- Elekta (EKTA-B.ST) announced today that it will establish a permanent office inCairo, Egypt, to address the shortage of radiotherapy delivery systems and software solutions that play an integral part in treating cancer and brain disorders. To strengthen i...

2021-02-22 15:03 7035

BioVaxys and BioElpida Sign Term Sheet for Clinical Grade BVX-0918A Bio-production

SIGNIFICANT ADVANCEMENT TOWARDS LAUNCH OF PHASE I OVARIAN CANCER VACCINE TRIAL VANCOUVER, BC, Feb. 18, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys" or "Company") announced today that it has signed a Term Sheet ("Term Sheet") with BioElpida S.A.S. ...

2021-02-18 21:00 6184

Crunchfish enrolled to leading international payment network's partner program

STOCKHOLM, Feb. 18, 2021 /PRNewswire/ -- Crunchfish AB ("Crunchfish") announces its enrolment into a leading international payment network's partner program with its Digital Cash solutions. As a technology partner, Crunchfish will get access to specifications and toolkits enabling integration wit...

2021-02-18 16:12 8079

Nel ASA: Fourth quarter 2020 financial results

OSLO, Norway, Feb. 18, 2021 /PRNewswire/ -- Nel ASA (Nel) reported revenues of NOK 229.1 million in the fourth quarter of 2020, up from NOK 175.9 million in the same quarter of 2019 and an EBITDA of negativeNOK 96.2 million (Q4 2019: -41.7) incl. one-offs, ramp-up cost and aNOK 20 million provisi...

2021-02-18 14:59 5777

RedHill Biopharma Announces First Patient Dosed in U.S. Phase 2/3 COVID-19 Outpatient Study with RHB-107

- The U.S. Phase 2/3 study with once-daily, orally-administered RHB-107 (upamostat) evaluates treatment of patients with symptomatic COVID-19 who do not require hospitalization - the vast majority of patients - RHB-107 is a novel serine protease inhibitor targeting human cell factors involved in...

2021-02-17 20:00 4410
1 ... 4445464748